ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0366

Why Is It so Difficult for AxSpA Patients to Find a Job? Results from the European Map of Axial Spondyloarthritis (EMAS)

Marco Garrido-Cumbrera1, Victoria Navarro-Compán2, Christine Bundy3, Souzi Makri4, Laura Christen5, José Correa-Fernández6, Sergio Sanz-Gomez6, Raj Mahapatra7, Carlos Jesús Delgado-Domínguez6 and Denis Poddubnyy8, 1Health & Territory Research (HTR), University of Seville, Sevilla, Spain, 2Rheumatology service, Hospital Universitario La Paz-IdiPaz, Madrid, Spain, 3Cardiff University, Cardiff, Wales, United Kingdom, 4Cyprus League Against Rheumatism (CYPLAR), Limassol, Cyprus, 5Novartis Pharma AG, Basel, Switzerland, 6Health & Territory Research (HTR), Universidad de Sevilla, Seville, Spain, 7Axial Spondyloarthritis International Federation (ASIF), London, United Kingdom, 8Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany

Meeting: ACR Convergence 2021

Keywords: Ankylosing spondylitis (AS), functional status, Patient reported outcomes, spondyloarthritis, work

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Aspects of Axial Spondyloarthritis (0357–0386)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: AxSpA is associated with substantial negative consequences regarding work status and career prospects. The aim is to identify factors associated with barriers to job access among European axSpA patients.

Methods: Data from 2,846 unselected patients participating in EMAS, an online survey (2017-2018) across 13 European countries, were analyzed. Difficulties in finding a job was assessed by the following item: “Do you think it is or it would be difficult for you to find a job because of your Spondylitis/Spondyloarthritis? (Yes/No)”. Differences in sociodemographic factors, patient-reported outcomes [BASDAI (0-10), spinal stiffness (3-12), functional limitation (0-54), and mental health status using the 12-item General Health Questionnaire (0-12)], employment, lifestyle habits, and comorbidities were assessed through Mann-Whitney and χ2 tests. Univariable and multivariable binary logistic regression were used to identify variables possibly explaining difficulties/perceived difficulties finding a job due to axSpA.

Results: Among the 1,823 patients who responded to difficulties/perceived difficulties in finding a job due to axSpA, mean age was 41.4±10.7 years, 62.6% female, 50.7% had a university degree, and 65.6% were married. 56.8% were employed, 8.4% unemployed, and 28.2% on sick leave. 1,357 (74.4%) reported they had or would have difficulties finding a job. Compared to those without difficulties, patients with difficulties were typically separated/divorced (11.4% vs 5.2%, p=0.001), less university educated (45.2% vs 66.5%, p< 0.001), and overweight/obese (50.6% vs 44.8%, p=0.034). Those with difficulties had increased restrictions when driving (37.0% vs 13.3%), or when using public transportation (40.2% vs 10.9%), had previously changed jobs because of axSpA (35.7% vs 21.7%), required adaptions to their car (26.3% vs 17.2%) or shoes (60.1% vs 40.6%), had longer diagnostic delay (7.7 vs 5.8 years), higher disease activity (BASDAI 6.0 vs 4.4), poorer mental health through GHQ-12 (6.0 vs 3.1), greater functional limitation (22.8 vs 9.2), and spinal stiffness (8.2 vs 6.4), as well as higher rates of anxiety (38.8% vs 18.8%), depression (35.2% vs 15.6%), and sleep disorders (47.0% vs 26.6%, all p< 0.001). In the logistic regression analysis, the qualitative factors associated with difficulties finding a job were restrictions using public transportation (OR=2.22), use of customized shoes (OR=1.58), not having university education (OR=0.53) and having had previously changed jobs due to barriers created by axSpA (OR=1.44). The quantitative factors associated were disease activity (OR=1.18), spinal stiffness (OR=1.13), poorer mental health (OR=1.09), and functional limitation (OR=1.04).

Conclusion: Three out of four axSpA patients had, or perceived they would have, difficulties in finding a job. Poor physical and mental health, together with the need for mobility adaptations, lower educational level, having changed job due to axSpA were factors associated with difficulties/perceived difficulties in finding a job. Early diagnosis, effective treatment and greater advocacy in the workplace are needed to enable axSpA patients to search for and remain in employment.

Table 2. Logistic regression analysis for variables associated with difficulty finding a job due to axSpA (N=1,502)


Disclosures: M. Garrido-Cumbrera, None; V. Navarro-Compán, Abbvie, 5, Lilly, 5, Novartis, 5, Pfizer, 5, UCB, 5, Janssen, 5; C. Bundy, Abbvie, 2, Celgene, 2, Janssen, 2, Lilly, 2, Novartis, 2, Pfizer, 2; S. Makri, None; L. Christen, Novartis, 3; J. Correa-Fernández, None; S. Sanz-Gomez, None; R. Mahapatra, None; C. Delgado-Domínguez, None; D. Poddubnyy, AbbVie, 2, 5, 6, Eli Lilly and Company, 2, 5, 6, MSD, 2, 5, 6, Novartis, 2, 5, 6, Pfizer, 2, 5, 6, UCB, 2, 6, BMS, 2, 6, Roche, 2, 6.

To cite this abstract in AMA style:

Garrido-Cumbrera M, Navarro-Compán V, Bundy C, Makri S, Christen L, Correa-Fernández J, Sanz-Gomez S, Mahapatra R, Delgado-Domínguez C, Poddubnyy D. Why Is It so Difficult for AxSpA Patients to Find a Job? Results from the European Map of Axial Spondyloarthritis (EMAS) [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/why-is-it-so-difficult-for-axspa-patients-to-find-a-job-results-from-the-european-map-of-axial-spondyloarthritis-emas/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/why-is-it-so-difficult-for-axspa-patients-to-find-a-job-results-from-the-european-map-of-axial-spondyloarthritis-emas/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology